22 Mar Exact Sciences lures leader of AbbVie’s top-selling Humira sales team
Exact Sciences Corp. is adding an executive of Abbott Laboratories/AbbVie, one of the biggest U.S. pharmaceutical companies, to lead its Cologuard campaign.
Exact created the position of president, Cologuard, for Mark Stenhouse; he will join Exact’s Madison headquarters on April 2.
Stenhouse is vice president, U.S. Immunology at AbbVie. He leads sales and marketing for Humira, an anti-inflammatory drug for psoriasis and rheumatoid arthritis. It has been the top-selling drug in the U.S. for the past five years. AbbVie, of North Chicago, Illinois, reported $28.2 billion in revenue last year and said Humira sales made up $18.4 billion of that.
Cologuard, a DNA stool test for colorectal cancer, is Exact’s only product on the market right now. But the company is working with Mayo Clinic researchers on several other tests to screen for different types of cancer.
Sorry, the comment form is closed at this time.